European Multicenter Registry Tracking Diagnosis and Treatment of Helicobacter pylori Infection in Adults
Led by Javier P. Gisbert · Updated on 2024-10-02
10000
Participants Needed
30
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Helicobacter pylori infection is a common chronic stomach infection linked to serious conditions like gastritis, peptic ulcers, and gastric cancer. This research aims to collect real-world data from European gastroenterologists on how H. pylori infection is diagnosed, treated, and managed over time. The goal is to analyze current clinical practices, evaluate treatment effectiveness and safety, and improve healthcare strategies across Europe.
The study uses a non-interventionist, prospective registry design involving up to ten gastroenterologists from 30 European countries. These doctors will record their routine clinical care of H. pylori infected adult patients over ten years using an electronic case report form. Data collected includes patient demographics, diagnosis methods, treatment details, adherence, side effects, and treatment outcomes.
Participants will be adults diagnosed with H. pylori infection seen in outpatient digestive clinics. Information on prescribed treatments and eradication confirmation will be gathered systematically. Researchers will monitor treatment prescriptions, adverse events, and treatment success rates during the study. The registry allows future analyses approved by the scientific committee, supporting better understanding and management of H. pylori infection.
CONDITIONS
Brief Title
European Registry on the Management of Helicobacter Pylori Infection
Research Team
J
Javier Pérez Gisbert, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Infected adult patients by Helicobacter pylori (18 years or older)
You will not qualify if you...
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - Up to 1 year
Participants who undergo routine care for Helicobacter pylori infection are observed and their diagnostic, treatment, and outcome data are collected over time.
Visits as part of routine clinical practice over 1 year
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
A Pilot Study Comparing 14-Day Vonoprazan-Based Dual, Triple, Bismuth Quadruple, Reverse Hybrid, and Lansoprazole-Based Therapies for First-Line Treatment of Helicobacter Pylori Infection
Study of Vonoprazan Dual and Triple Therapy Compared to PPI Triple Therapy to Treat Helicobacter Pylori Infection in Adults
European Multicenter Registry Tracking Diagnosis and Treatment of Helicobacter pylori Infection in Adults
Study of Argon Plasma Activated Liquid to Treat Helicobacter pylori Infection During Endoscopy
Comparing Direct Stomach Treatment vs. Pre-Prepared Solution
Study of H. Pylori Infection Recurrence and Influential Factors in Adults Aged 18 to 75 in Sohag Government
Finding the Best Screening Method to Prevent Gastric Cancer by Detecting H. pylori Infection in Adults
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg).
Diego Casas Deza, Javier Alcedo, Miguel Lafuente...
Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg).